XML 20 R10.htm IDEA: XBRL DOCUMENT v3.21.1
Stock Warrants
3 Months Ended
Mar. 31, 2020
Convertible Debt [Abstract]  
Stock Warrants

Note 4. Stock Warrants

 

At March 31, 2021, our Company had warrants outstanding to purchase 141,365 of our Company’s common stock at $0.02 per share. The warrants were granted in 2014 to two individuals who acquired convertible debentures from the Company in 2014. The warrants are exercisable two years after issuance and expire seven years after issuance. The fair value of the warrants was determined using the Black-Scholes pricing model. The relative fair value of the warrants was recorded as a discount to the notes payable with an offsetting credit to additional paid-in capital since our Company determined that the warrants were an equity instrument in accordance with FASB ASC 815. The debt discount related to the warrant issuances has been accreted through interest expense over the term of the notes payable.

 

The following table summarizes our Company’s warrant position at March 31, 2021 and December 31, 2020:

 

                Weighted Average  
    Number     Exercise     Exercise  
    of Shares     Price     Price  
Outstanding warrants -                  
December 31, 2020     141,365     $ 0.02     $ 0.02  
                         
Outstanding warrants -                        
March 31, 2021     141,365     $ 0.02     $ 0.02  
                         
Weighted average remaining                        
contractual life (years)     .27                  
                         
Exercisable warrants -                        
March 31, 2021     141,365     $ 0.02     $ 0.02  

 

The aggregate intrinsic value of warrants outstanding and exercisable as of March 31, 2021 was approximately $19,800. The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying warrants and the closing stock price of $0.16 for our Company’s common stock on March 31, 2021.